{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T16:52:56Z","timestamp":1782319976338,"version":"3.54.5"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T00:00:00Z","timestamp":1600646400000},"content-version":"vor","delay-in-days":20,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Federal Office of Public Health, Switzerland"},{"name":"Competence Centre"},{"name":"MilMedBiol"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Travel Medicine and Infectious Disease"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.tmaid.2020.101876","type":"journal-article","created":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T03:08:31Z","timestamp":1599880111000},"page":"101876","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Immunogenicity and safety of the tick-borne encephalitis vaccination (2009\u20132019): A systematic review"],"prefix":"10.1016","volume":"37","author":[{"given":"John Ethan","family":"Rampa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena Hervius","family":"Askling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phung","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7979-076X","authenticated-orcid":false,"given":"Kyra Denise","family":"Zens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nejla","family":"G\u00fcltekin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeno","family":"Stanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1075-7010","authenticated-orcid":false,"given":"Patricia","family":"Schlagenhauf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmaid.2020.101876_bib1","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.4049\/jimmunol.1300293","article-title":"Tick-borne encephalitis (TBE) and hepatitis B nonresponders feature different immunologic mechanisms in response to TBE and influenza vaccination with involvement of regulatory T and B cells and IL-10","volume":"191","author":"Garner-Spitzer","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.tmaid.2020.101876_bib2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/cid\/ciz176","article-title":"Tick-borne encephalitis vaccine failures: a 10-year retrospective study supporting the rationale for adding an extra priming dose in individuals starting at age 50 years","volume":"70","author":"Hansson","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tmaid.2020.101876_bib3","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10354-010-0758-5","article-title":"Tick-borne encephalitis and golden agers: position paper of the International Scientific Working Group on Tick-borne encephalitis (ISW-TBE)","volume":"160","author":"Jelenik","year":"2010","journal-title":"Wien Med Wochenschr"},{"key":"10.1016\/j.tmaid.2020.101876_bib4","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1093\/infdis\/jir122","article-title":"A tick-borne encephalitis virus vaccine based on the European prototype strain induces broadly reactive cross-neutralizing antibodies in humans","volume":"203","author":"Orlinger","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tmaid.2020.101876_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2018.09.010","article-title":"Travel and tick-borne diseases: lyme disease and beyond","author":"Parola","year":"2018","journal-title":"Trav Med Infect Dis"},{"key":"10.1016\/j.tmaid.2020.101876_bib6","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.tmaid.2018.08.008","article-title":"Tick-borne pathogens in removed ticks Veneto, northeastern Italy: a cross-sectional investigation","volume":"26","author":"Beltrame","year":"2018","journal-title":"Trav Med Infect Dis"},{"key":"10.1016\/j.tmaid.2020.101876_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2018.11.010","article-title":"Ticks and tick-borne encephalitis in Europe: challenges for travel medicine","author":"Haditsch","year":"2018","journal-title":"Trav Med Infect Dis"},{"key":"10.1016\/j.tmaid.2020.101876_bib9","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1016\/j.vaccine.2010.03.024","article-title":"Decreased antibody titers and booster responses in tick-borne encephalitis vaccinees aged 50\u201390 years","volume":"28","author":"Weinberger","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2020.101876_bib10","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1016\/j.vaccine.2017.12.081","article-title":"Second five-year follow-up after a booster vaccination against tick-borne encephalitis following different primary vaccination schedules demonstrates at least 10 years antibody persistence","volume":"37","author":"Beran","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2020.101876_bib11","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/jmv.25316","article-title":"Ability of inactivated vaccines based on far\u2010eastern tick\u2010borne encephalitis virus strains to induce humoral immune response in originally seropositive and seronegative recipients","volume":"91","author":"Maikova","year":"2019","journal-title":"J Med Virol"},{"key":"10.1016\/j.tmaid.2020.101876_bib12","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1089\/vbz.2013.1569","article-title":"The role of game (wild boar and roe deer) in the spread of tick-borne encephalitis in the Czech Republic","volume":"14","author":"Kriz","year":"2014","journal-title":"Vector Borne Zoonotic Dis"},{"key":"10.1016\/j.tmaid.2020.101876_bib13","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.4161\/hv.29984","article-title":"Immunogenicity against Far Eastern and Siberian subtypes of tick-borne encephalitis (TBE) virus elicited by the currently available vaccines based on the European subtype: systematic review and meta-analysis","volume":"10","author":"Domnich","year":"2014","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.tmaid.2020.101876_bib14","doi-asserted-by":"crossref","DOI":"10.1186\/s13071-019-3346-6","article-title":"Repeated isolation of tick-borne encephalitis virus from adult Dermacentor reticulatus ticks in an endemic area in Germany","author":"Chitimia-Dobler","year":"2019","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.tmaid.2020.101876_bib15","series-title":"Tick-borne encephalitis annual epidemiological report for 2018","year":"2019"},{"key":"10.1016\/j.tmaid.2020.101876_bib16","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.vaccine.2015.02.038","article-title":"Five year follow-up after primary vaccination against tick-borne encephalitis in children","volume":"33","author":"Wittermann","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2020.101876_bib17","first-page":"Cd000977","article-title":"Vaccines for preventing tick-borne encephalitis","author":"Demicheli","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.tmaid.2020.101876_bib18","doi-asserted-by":"crossref","first-page":"736","DOI":"10.4161\/hv.20058","article-title":"Antibody persistence after two vaccinations with either FSME-IMMUN\u00ae Junior or ENCEPUR\u00ae Children followed by third vaccination with FSME-IMMUN\u00ae Junior","volume":"8","author":"Prymula","year":"2012","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.tmaid.2020.101876_bib19","doi-asserted-by":"crossref","first-page":"4680","DOI":"10.1016\/j.vaccine.2010.04.047","article-title":"Comparison of immunogenicity and safety between two paediatric TBE vaccines","volume":"28","author":"P\u00f6llabauer","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2020.101876_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2019.01.014","article-title":"Tick-borne encephalitis in Europe and Russia: review of pathogenesis, clinical features, therapy, and vaccines","author":"Ruzek","year":"2019","journal-title":"Antivir Res"},{"key":"10.1016\/j.tmaid.2020.101876_bib21","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1016\/j.vaccine.2019.03.032","article-title":"Seropersistence and booster response following vaccination with FSME-IMMUN in children, adolescents, and young adults","volume":"37","author":"P\u00f6llabauer","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2020.101876_bib22","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.vaccine.2012.12.075","article-title":"Factors associated with seroimmunity against tick borne encephalitis virus 10 years after booster vaccination","volume":"31","author":"Paulke-Korinek","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2020.101876_bib23","doi-asserted-by":"crossref","first-page":"7559","DOI":"10.1016\/j.vaccine.2007.08.024","article-title":"Field effectiveness of vaccination against tick-borne encephalitis","volume":"25","author":"Heinz","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2020.101876_bib24","doi-asserted-by":"crossref","first-page":"7396","DOI":"10.1016\/j.vaccine.2010.09.003","article-title":"Tick-borne encephalitis after vaccination: vaccine failure or misdiagnosis","volume":"28","author":"Grgi\u010d-Vitek","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2020.101876_bib25","doi-asserted-by":"crossref","first-page":"423","DOI":"10.2165\/00019053-199915050-00001","article-title":"Pharmacoeconomic evaluation in the real world: effectiveness versus efficacy studies","volume":"15","author":"Revicki","year":"1999","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.tmaid.2020.101876_bib26","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.provac.2011.07.012","article-title":"Protective antibody titer for patients vaccinated against tickborne encephalitis virus","volume":"4","author":"Leonova","year":"2011","journal-title":"Procedia Vaccinol"},{"key":"10.1016\/j.tmaid.2020.101876_bib27","doi-asserted-by":"crossref","first-page":"7210","DOI":"10.1128\/JVI.03690-13","article-title":"Mechanism and significance of cell type-dependent neutralization of flaviviruses","volume":"88","author":"Mukherjee","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.tmaid.2020.101876_bib28","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.tmaid.2020.101876_bib29","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1080\/14760584.2017.1358620","article-title":"Systematic literature review comparing rapid 3-dose administration of the GSK tick-borne encephalitis vaccine with other primary immunization schedules","volume":"16","author":"Galgani","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.tmaid.2020.101876_bib30","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3109\/08830185.2010.483028","article-title":"Are anti-infectious vaccinations safe and effective in patients with autoimmunity?","volume":"29","author":"Salemi","year":"2010","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.tmaid.2020.101876_bib31","doi-asserted-by":"crossref","first-page":"7307","DOI":"10.1016\/j.vaccine.2011.07.089","article-title":"Prevention of tick-borne encephalitis by FSME-IMMUN\u00ae vaccines: review of a clinical development programme","volume":"29","author":"Loew-Baselli","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2020.101876_bib32","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrneurol.2012.8","article-title":"Vaccination against infection in patients with multiple sclerosis","volume":"8","author":"Loebermann","year":"2012","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.tmaid.2020.101876_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056974","article-title":"Serologic vaccination response after solid organ transplantation: a systematic review","volume":"8","author":"Eckerle","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.tmaid.2020.101876_bib34","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3201\/eid1901.120458","article-title":"Vaccination and tick-borne encephalitis, central Europe","volume":"19","author":"Heinz","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.tmaid.2020.101876_bib35","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/j.vaccine.2015.12.057","article-title":"Comparable immune responsiveness but increased reactogenicity after subcutaneous versus intramuscular administration of tick borne encephalitis (TBE) vaccine","volume":"34","author":"Hopf","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2020.101876_bib36","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1016\/j.vaccine.2014.01.072","article-title":"Irregular tick-borne encephalitis vaccination schedules: the effect of a single catch-up vaccination with FSME-IMMUN. A prospective non-interventional study","volume":"32","author":"Schosser","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2020.101876_bib37","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.vaccine.2011.11.061","article-title":"Immunogenicity of delayed TBE-vaccine booster","volume":"30","author":"Askling","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2020.101876_bib38","doi-asserted-by":"crossref","first-page":"551","DOI":"10.4161\/hv.5.8.8571","article-title":"Seropersistence of tick-borne encephalitis antibodies, safety and booster response to FSME-IMMUN \u00ae 0.5 ml in adults aged 18-67 years","volume":"5","author":"Loew-Baselli","year":"2009","journal-title":"Hum Vaccine"},{"key":"10.1016\/j.tmaid.2020.101876_bib39","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.21101\/cejph.a5271","article-title":"Effectiveness of primary vaccination against tick-borne encephalitis in employees of the armed forces","volume":"26","author":"Dorko","year":"2018","journal-title":"Cent Eur J Publ Health"},{"key":"10.1016\/j.tmaid.2020.101876_bib40","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1016\/j.vaccine.2014.06.028","article-title":"Five year follow-up after a first booster vaccination against tick-borne encephalitis following different primary vaccination schedules demonstrates long-term antibody persistence and safety","volume":"32","author":"Beran","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2020.101876_bib41","doi-asserted-by":"crossref","first-page":"7021","DOI":"10.1016\/j.vaccine.2009.09.069","article-title":"Characteristics of antibody responses in tick-borne encephalitis vaccination breakthroughs","volume":"27","author":"Stiasny","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2020.101876_bib42","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/joim.12625","article-title":"Tick-borne encephalitis in patients vaccinated against this disease","volume":"282","author":"Lotri\u010d-Furlan","year":"2017","journal-title":"J Intern Med"},{"key":"10.1016\/j.tmaid.2020.101876_bib43","first-page":"20756","article-title":"Epidemiology of tick-borne encephalitis in Switzerland","volume":"19","author":"Schuler","year":"2014","journal-title":"2005 to 2011. Eurosurveillance"},{"key":"10.1016\/j.tmaid.2020.101876_bib44","doi-asserted-by":"crossref","first-page":"7027","DOI":"10.1016\/j.vaccine.2009.09.068","article-title":"Booster vaccinations against tick-borne encephalitis: 6 Years follow-up indicates long-term protection","volume":"27","author":"Paulke-Korinek","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2020.101876_bib45","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1016\/j.vaccine.2010.02.001","article-title":"Vaccine failures after active immunisation against tick-borne encephalitis","volume":"28","author":"Andersson","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2020.101876_bib46","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.vaccine.2008.10.003","article-title":"Antibody response following administration of two paediatric tick-borne encephalitis vaccines using two different vaccination schedules","volume":"27","author":"Wittermann","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2020.101876_bib47","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1016\/j.vaccine.2010.04.075","article-title":"Clinical evaluation to determine the appropriate paediatric formulation of a tick-borne encephalitis vaccine","volume":"28","author":"P\u00f6llabauer","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2020.101876_bib48","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1128\/JVI.02985-15","article-title":"Molecular basis of the divergent immunogenicity of two pediatric tick-borne encephalitis virus vaccines","volume":"90","author":"Beck","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.tmaid.2020.101876_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034145","article-title":"Age affects quantity but not quality of antibody responses after vaccination with an inactivated flavivirus vaccine against tick-borne encephalitis","author":"Stiasny","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.tmaid.2020.101876_bib50","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.vaccine.2008.12.057","article-title":"Long-term persistence of tick-borne encephalitis antibodies in children 5 years after first booster vaccination with Encepur\u00ae Children","volume":"27","author":"Wittermann","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2020.101876_bib51","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.vaccine.2008.11.082","article-title":"Long-term persistence of tick-borne encephalitis antibodies in adults 5 years after booster vaccination with Encepur\u00ae Adults","volume":"27","author":"Plentz","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2020.101876_bib52","first-page":"375","article-title":"Immunogenicity of a booster vaccination against tick-borne encephalitis","volume":"85","author":"Be\u0161kovnik","year":"2016","journal-title":"Zdr Vestn"},{"key":"10.1016\/j.tmaid.2020.101876_bib53","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1016\/j.vaccine.2017.03.059","article-title":"Seropersistence of TBE virus antibodies 10 years after first booster vaccination and response to a second booster vaccination with FSME-IMMUN 0.5 mL in adults","volume":"35","author":"Konior","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2020.101876_bib54","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.vaccine.2015.12.029","article-title":"Tick-borne encephalitis (TBE) vaccine to medically immunosuppressed patients with rheumatoid arthritis: a prospective, open-label, multi-centre study","volume":"34","author":"Hertzell","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2020.101876_bib55","doi-asserted-by":"crossref","first-page":"8053","DOI":"10.1016\/j.vaccine.2010.10.002","article-title":"Antibody dynamics after tick-borne encephalitis and measles\u2013mumps\u2013rubella vaccination in children post early thymectomy","volume":"28","author":"Zlamy","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2020.101876_bib56","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1016\/j.vaccine.2018.03.076","article-title":"Allergic patients with and without allergen-specific immunotherapy mount protective immune responses to tick-borne encephalitis vaccination in absence of enhanced side effects or propagation of their Th2 bias","volume":"36","author":"Garner-Spitzer","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2020.101876_bib57","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/tav020","article-title":"Analysis of delayed TBE-vaccine booster after primary vaccination: Table 1","volume":"23","author":"Aerssens","year":"2016","journal-title":"J Trav Med"},{"key":"10.1016\/j.tmaid.2020.101876_bib58","doi-asserted-by":"crossref","first-page":"221","DOI":"10.21873\/invivo.11049","article-title":"Prevalence of neurotropic viruses in malignant glioma and their onco-modulatory potential","volume":"31","author":"Strojnik","year":"2017","journal-title":"Vivo (Brooklyn)"},{"key":"10.1016\/j.tmaid.2020.101876_bib59","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1016\/j.vaccine.2010.04.002","article-title":"Surveillance for adverse events following immunization (AEFI) in Switzerland\u20141991\u20132001","volume":"28","author":"Schumacher","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2020.101876_bib60","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/INF.0000000000001073","article-title":"Anaphylaxis After immunization of children and adolescents in Germany","volume":"35","author":"Oberle","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.tmaid.2020.101876_bib61","first-page":"S332","article-title":"Poster sessions","volume":"39","author":"Zlamy","year":"2009","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.tmaid.2020.101876_bib62","doi-asserted-by":"crossref","first-page":"900.3","DOI":"10.1136\/annrheumdis-2015-eular.5567","article-title":"AB0030 persistence of humoral and cellular immunity against tick-borne-encephalitis vaccination in patients with juvenile idiopathic arthritis (JIA)","volume":"74","author":"Robrade","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.tmaid.2020.101876_bib63","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/imm.12002","article-title":"Poster sessions","volume":"137","author":"Aberle","year":"2012","journal-title":"Immunology"},{"key":"10.1016\/j.tmaid.2020.101876_bib64","first-page":"246","article-title":"Immunogenicity and safety of tick-borne encephalitis vaccination in healthy elderly individuals","volume":"18","author":"Wanke","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.tmaid.2020.101876_bib65","first-page":"12","article-title":"Oral communications","volume":"115","author":"Jim\u00e9nez","year":"2014","journal-title":"Basic Clin Pharmacol Toxicol 2014"},{"key":"10.1016\/j.tmaid.2020.101876_bib66","doi-asserted-by":"crossref","first-page":"5172","DOI":"10.1016\/j.vaccine.2009.06.068","article-title":"Immune thrombocytopenic purpura reactivation after tick-borne encephalitis vaccination","volume":"27","author":"Benz","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2020.101876_bib67","first-page":"21","article-title":"Post tick-borne encephalitis (TBE) vaccination narcolepsy-cataplexy","volume":"22","author":"Hidalgo Pareja","year":"2015","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.tmaid.2020.101876_bib68","first-page":"735","article-title":"Acute facial paresis after FSME (tick-borne encephalitis) vaccination","volume":"77","author":"Heininger","year":"2011","journal-title":"P\u00e4diatrische Prax"},{"key":"10.1016\/j.tmaid.2020.101876_bib69","author":"Bundesamt f\u00fcr Gesundheit Bag"},{"key":"10.1016\/j.tmaid.2020.101876_bib70","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/jmv.23313","article-title":"Persistence of immunity to tick-borne encephalitis after vaccination and natural infection","volume":"84","author":"Baldovin","year":"2012","journal-title":"J Med Virol"},{"key":"10.1016\/j.tmaid.2020.101876_bib71","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0264-410X(98)00272-2","article-title":"Vaccination against tick-borne encephalitis under therapeutic immunosuppression. Reduced efficacy in heart transplant recipients","volume":"17","author":"Dengler","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2020.101876_bib72","unstructured":"Antworten auf h\u00e4ufig gestellte Fragen zur FSME-Impfung n.d. https:\/\/www.rki.de\/SharedDocs\/FAQ\/FSME\/FSME-Impfung\/FSME-Impfung.html (accessed December 16, 2019)."},{"key":"10.1016\/j.tmaid.2020.101876_bib74","unstructured":"Fsme - Fr\u00fchsommermeningoenzephalitis n.d. https:\/\/www.gesundheit.gv.at\/leben\/gesundheitsvorsorge\/impfungen\/fsme (accessed December 16, 2019)."},{"key":"10.1016\/j.tmaid.2020.101876_bib75","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3390\/pharmacy6040125","article-title":"The role of community pharmacists in travel Health and vaccination in Switzerland","volume":"6","author":"Leuthold","year":"2018","journal-title":"Pharmacy"},{"key":"10.1016\/j.tmaid.2020.101876_bib76","unstructured":"Schweizer Armee reagiert auf die Zunahme der Erkrankungen durch Zeckenstiche n.d. https:\/\/www.admin.ch\/gov\/de\/start\/dokumentation\/medienmitteilungen.msg-id-10546.html (accessed January 9, 2020)."},{"key":"10.1016\/j.tmaid.2020.101876_bib77","first-page":"448","article-title":"ELISA for IgM and IgG antibodies against tick-borne encephalitis virus: quantification and standardization of results","volume":"255","author":"Hofmann","year":"1983","journal-title":"Zentralblatt Fur Bakteriol Mikrobiol Und Hyg - Abt 1 Orig A"},{"key":"10.1016\/j.tmaid.2020.101876_bib78","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4049\/jimmunol.109.1.129","article-title":"Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes","volume":"109","author":"Engvall","year":"1972","journal-title":"J Immunol"},{"key":"10.1016\/j.tmaid.2020.101876_bib79","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1517\/14712590903066711","article-title":"Serological response to tick-borne encephalitis (TBE) vaccination in the elderly \u2013 results from an observational study","volume":"9","author":"J\u00edlkov\u00e1","year":"2009","journal-title":"Expet Opin Biol Ther"},{"key":"10.1016\/j.tmaid.2020.101876_bib80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100860","article-title":"Factors determining immunological response to vaccination against tick-borne encephalitis virus in older individuals","volume":"9","author":"Lindblom","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.tmaid.2020.101876_bib81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/femspd\/ftu002","article-title":"Anti-tick-borne encephalitis (TBE) virus neutralizing antibodies dynamics in natural infections versus vaccination","volume":"73","author":"Remoli","year":"2015","journal-title":"Pathog Dis"},{"key":"10.1016\/j.tmaid.2020.101876_bib82","doi-asserted-by":"crossref","first-page":"98","DOI":"10.21101\/cejph.a3634","article-title":"Vaccination of patients with diabetes mellitus - a retrospective study","volume":"19","author":"Ma\u010far","year":"2011","journal-title":"Cent Eur J Publ Health"},{"key":"10.1016\/j.tmaid.2020.101876_bib83","unstructured":"Swiss vaccination schedules. Fed off Public Heal n.d. https:\/\/www.bag.admin.ch\/bag\/de\/home\/gesund-leben\/gesundheitsfoerderung-und-praevention\/impfungen-prophylaxe\/schweizerischer-impfplan.html (accessed December 16, 2019)."}],"container-title":["Travel Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893920303720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893920303720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:08:11Z","timestamp":1761487691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477893920303720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":81,"alternative-id":["S1477893920303720"],"URL":"https:\/\/doi.org\/10.1016\/j.tmaid.2020.101876","relation":{},"ISSN":["1477-8939"],"issn-type":[{"value":"1477-8939","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and safety of the tick-borne encephalitis vaccination (2009\u20132019): A systematic review","name":"articletitle","label":"Article Title"},{"value":"Travel Medicine and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmaid.2020.101876","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101876"}}